Lakefront Biotherapeutics American Depositary Shares (LKFT)

Lakefront Biotherapeutics American Depositary Shares (LKFT) is listed on Nasdaq, where it has traded since December 18, 2008.

Listed On
Nasdaq
Listed Since
December 18, 2008
Employees
452
Market Cap
$2.1B

About Lakefront Biotherapeutics American Depositary Shares

Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 77 institutions reported holding LKFT, with 32.1 million shares worth $960.3 million in aggregate. The largest reported holder was Gilead Sciences, with 16.7 million shares worth $500.2 million. Of the 5 largest holders listed below, 2 added shares and 3 held their positions unchanged during the quarter.

InstitutionSharesValueQuarter change
Gilead Sciences16,707,477$500MUnchanged
Tang Capital Management3,785,991$114MUnchanged
Madison Avenue Partners3,447,807$103MAdded 39.86%
Prosight Management2,043,344$61MAdded 31.83%
Ecor1 Capital1,667,119$50MUnchanged

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is LKFT?

Lakefront Biotherapeutics American Depositary Shares (LKFT) is listed on Nasdaq, where it has traded since December 18, 2008.

Who are the largest institutional holders of LKFT?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of LKFT were Gilead Sciences, Tang Capital Management and Madison Avenue Partners.

How many institutions own LKFT?

77 institutions reported a position in LKFT for the quarter ended June 30, 2026, worth $960.3 million in total.

Did institutions buy or sell LKFT last quarter?

Of the 5 largest reported holders, 2 added shares and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for LKFT.

Every reported institutional holder, plus insider and congressional trades in LKFT, on SentiSense.